OCT 2014 ARTICLE LIST >>
PharmaTutor (October- 2014)
ISSN: 2347 - 7881
(Volume 2, Issue 10)
Received On: 12/08/2014; Accepted On: 19/08/2014; Published On: 01/10/2014
AUTHORS: Asif I Bhim*, Vineet Jain, Hasumati Raj
Shree Dhanvantary Pharmacy College,
Kim, Gujarat, India
bhimiqbal23@gmail.com
ABSTRACT:
Itopride Hydrochloride is a novel, synthesized, gastro prokinetic drug, which stimulates gastrointestinal motor activity through the synergistic effects of dopamine D2-receptor blockade and acetylcholine esterase inhibitors. Chemically, it is N-[[4-[2-(Dimethyl amino) ethoxy] phenyl] methyl]-3, 4-dimethoxy benzamide hydrochloride. Benzamide structure, amide and ether linkages in the drug molecule make it susceptible to degradation. Thus a prokinetic drug like Itopride Hydrochloride by virtue of its efficacy and tolerability could be considered as a drug of first choice and a welcome addition to the drug armamentarium for the symptomatic treatment of NUD (non-ulcer Dyspepsia) and other gastric motility disorders including functional bowel disorders. This review consists of various analytical methods for determination of Itopride Hydrochloride in various marketed pharmaceutical preparation and in biological fluids. Analytical method consists of various spectroscopic methods, chromatographic methods and other methods.
How to cite this article: AI Bhim, V Jain, R Hasumati; A Review: Determination of Itopride Hydrochloride in biological fluid and Pharmaceutical Dosage Forms; PharmaTutor; 2014; 2(10); 38-44
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. Ambrish T.*, Rahul M. Itopride: An updated review of its pharmacological properties and use as a prokinetic. International Journal of Institutional Pharmacy and Life Sciences, 2013; 3(2): 13-19
2. abcam.com/itopride-hydrochloride-HSR-803-ab143652.html
3. Shankar S.¹, Deepak S.¹, Sunil O.², Puspendra SN.¹*. Formulation and evaluation of Itopride Hydrochloride sustained release pellets. Innovare journal of life science,2013; 1(2): 11-16
4. Seema G. Itopride: A Novel Prokinetic Agent. JK Science, 2004; 6(2): 106-108
5. en.wikipedia.org/wiki/Itopride
6. drugs.com/cons/Itopride.html
7. Zhao Y. Hubei Provincial Institute for Drug Control, Wuhan 430064. Determination of Itopride Hydrochloride in capsule formulation by HPLC. Tianjin pharmacy, 2000-2002
8. Pavel P., Josef K., Jan M. Optimized method for the determination of itopride in human plasma by high-performance liquid chromatography with flourometric detection. Journal of Chromatography B, 2009; 877(8-9): 842-846
9. Neeraj K., Himani A., Pravin M., Janhavi RR., Kakasaheb RM and Shivajirao SK. Chromatographic determination of Itopride Hydrochloride in the presence of its degradation products. Journal of separation science, 2005; 28(13): 1566-1576
10. Rajesh S.*, Ganesh PM and Subhash CC. Development and Validation of RP-HPLC Method for the Simultaneous determination of Rabeprazole Sodium and Itopride Hydrochloride in Solid Dosage Form. E-Journal of chemistry, 2010; 7(3): 947-952
11. Rajesh KP.*, Bhuvan PR., Bhavesh HP., Laxman JP. Reverse Phase High Performance Liquid Chromatographic method for the simultaneous estimation of Esomeprazole and Itopride in Capsule. Scholar research Library, 2010; 2(1): 251-260
12. Vidya VD.¹, Ramesh TS.¹, Shashikumar NM.¹, Harsha NT.¹, Sreedevi P.¹. Determination of Itopride Hydrochloride in its pharmaceutical preparation and in bulk drug. JPC-Journal of planner chromatography- Modern TLC, 2006; 19(110): 319-323
13. Suganthi A.*, Sofiya J., and Ravi TK. Simultaneous HPTLC determination of Rabeprazole sodium and Itopride Hydrochloride in solid dosage form. Indian Journal of Pharmaceutical Science, 2008; 70(3): 366–368
14. Vineeta K.*, Deepak B., Vilasrao K. Stability indicating high performance thin-layer chromatographic method for simultaneous estimation of pantoprazole sodium and Itopride Hydrochloride in combined dosage form. Journal of Pharmaceutical Analysis, 2011; 1(4): 275–283
15. Santosh UZ.¹*, Paresh IK.¹, Jitendra WG.¹, Anantwar SP.¹, Sahebrao SB¹. Spectrophotometric method development and validation of Itopride Hydrochloride in bulk and dosage form. International Journal of Drug Delivery, 2010; 340-343
16. Gupta KR.*, R Joshi RR., Chawla RB and Wadodkar SG. UV Spectrophotometric Method for the Estimation of Itopride Hydrochloride in Pharmaceutical Formulation. E-Journal of Chemistry, 2010; 7(S1): S49-S54
17. Balram C.*¹, Anju G.¹, Sukhbir LK². Spectrophotometric method for estimation of Itopride Hydrochloride from tablets formulations using Methyl orange reagent. International Journal of Pharmacy and Pharmaceutical Sciences, 2009; 1(1): 159-162
18. Pattanayaka, Sharma Ra* & Chaturvedi SCa. Simultaneous estimation of Rabeprazole sodium and Itopride Hydrochloride. Analytical Letters, 2007; 40(12): 2288-2294
19. Deepak B., Vinash P., Vineeta K.*, Vilasrao K. Simultaneous estimation of Pantoprazole sodium and Itopride Hydrochloride in pharmaceutical dosage form by first order derivative UV spectrophotometry. Asian Journal of Pharmaceutical and Clinical Research, 2010; 3(3): 221-224
20. Mohamed I.W., Fawzia I., Manal IE., Samah AE. Stability-Indicating Spectrofluorimetric Method for Determination of Itopride Hydrochloride in Raw Material and Pharmaceutical Formulations. Journal of Fluorescence, 2013; 23(6): 1293-1300
21. Payal J.*, Suvarna B., Bhagwat AM., Vishwanath K.¹ and Jadhav RK². Identification of Forced Degradation Products of Itopride by LC-PDA and LC-MS. Indian Journal of Pharmaceutical Science, 2011; 73(3): 287–291
22. Heon WL. Ji-Hyung S., Seung-Ki C., Kyung-Tae L. Determination of itopride in human plasma by liquid chromatography coupled to tandem mass spectrometric detection: Application to a bioequivalence study. Analytica Chimica Acta, 2007; 583(1): 118–123
23. Anirbandeep B., Uttam B., Animesh G., Bappaditya C., Amlon KS., Tapan KP. LC-MS Simultaneous estimation of Itopride Hydrochloride and Domperidone in human plasma. Chromatographia, 2009; 69: 1233-1241
.png)
